Wednesday, April 22, 2026
33.4 C
Bengaluru

Interesting, Engaving & Relevant

[wpfilebase tag=file id=88 tpl=download-button /]

Inside this Issue

1. Pharma Success Story: Medical Rep to Country Manager by Deepak Sharma
Deepak Sharma shares his story of finding success in Pharma and what it took him to get there.

2. Year-end Performance Reviews: Retrospective or Prospective? by K. Hariram
As the financial year comes to a close and performance reviews are around the bend, how should this important exercise be conducted? 

3. The Five Drivers of Brand Equity by Vivek Hattangadi
A clear formula to audit and increase the perception and recall of your brand in the Doctor’s mind.

4. Case Study: Moving to a Competency-based HR System in Pharma by Diksha Fouzdar
In the wake of an acquisition and FDA warning, a large pharma company decided to completely overhaul its existing HR systems – here is the process and outcome.

Hot this week

Precision Farming Market to Witness Promising Growth Opportunities by 2024-2035

Driven by the ongoing efforts to overcome the inefficiencies...

The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy

In 1989, oncology in India was not a business...

Ritesh Desai has joined Standard Chartered India as Executive Director

Ritesh Desai has joined Standard Chartered India as Executive...

The Healthium Odyssey: From Sutures to Scalpel-Sharp Innovation

The story of Healthium is not just one of...

Topics

Precision Farming Market to Witness Promising Growth Opportunities by 2024-2035

Driven by the ongoing efforts to overcome the inefficiencies...

The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

Ritesh Desai has joined Standard Chartered India as Executive Director

Ritesh Desai has joined Standard Chartered India as Executive...

A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act

Sun Pharma’s Odyssey and Organon’s Second Act – And...

The Semaglutide Gold Rush: Miracle Cure or Market Mirage?

The Indian Pharmaceutical Market (IPM) has entered a definitive...
spot_img

Related Articles

spot_imgspot_img